Tomorrow, at a meeting with analysts, Amgen is widely expected to do somethingthat may represent the end of the biotechnology industry as we know it: pay a dividend.
But the fact that entrepreneurs continue to take extraordinary risks for a small expected return (from a probabilistic standpoint) indicates thatsomething else is balancing the scales.
What Andre finds really difficult are conversations where someone is disagreeing with him, conversations where he's being expected to talk about somethingthat he finds difficult or uncomfortable or where he expects someone will disagree with him.